Mendel.ai Company
Mendel.ai transforms unstructured EMR data and clinical literature into comprehensive and compliant analytics-ready data. Mendel uses their novel AI aided by clinical experts to streamline global oncology research by organizing real-world data and automating clinical trials. They build software to solve problems at each stage of the clinical trial process, from feasibility to post-trial pharmacovigilance.
Investors
.png)
.png)
.png)
.png)
(Reupload).png)
.jpeg)
(Reupload).png)
.png)
.png)
Technology:
Artificial Intelligence, Biotechnology, Clinical Trials, Computer Vision, Data Visualization, Health Care, Life Science, Machine Learning, Medical
Industry:
Data Processing
Headquarters:
San Jose, California, United States
Founded Date:
2017-02-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
25400000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-06-07
Last Funding Type:
Series A
Register and Claim Ownership